Shanghai Pharmaceuticals to acquire Cardinal Health’s distribution business in China for $557m
In a significant move within the pharmaceutical sector, Shanghai Pharmaceuticals Holding Co. has agreed to purchase the Chinese pharmaceutical distribution business of US-based Cardinal Health ... Read More
Sanofi strikes $805m deal with Principia Biopharma for multiple sclerosis drug development
Sanofi and Principia Biopharma have announced a significant partnership to develop and commercialize PRN2246, a promising oral drug candidate for multiple sclerosis (MS) and other ... Read More
Valeant Pharmaceuticals to divest Sprout Pharmaceuticals in strategic move
Valeant Pharmaceuticals International has announced a significant transaction involving the sale of Sprout Pharmaceuticals back to its original owners. This strategic divestiture includes a deal ... Read More
Pfizer exits Chinese generic drugs JV, Hisun-Pfizer Pharmaceuticals
In a significant shift within the pharmaceutical industry, Pfizer Inc. has announced its decision to exit the Hisun-Pfizer Pharmaceuticals joint venture by divesting its 49% ... Read More